RNA-seq analysis revealed significant genetic upregulation of NOX4 in cisplatin-AKI mice, while in rIPC-treated AKI mice, NOX4 expression decreased to a level comparable to that in the control group (Figure 4A), which suggested that NOX4 might be involved in the renoprotective effect of rIPC. The gene discussed is NOX4; the disease is acute kidney injury.